aberrant DNA hypermethylation
DNA methylation-sensitive enhancers
altered DNA methylation
patterns of DNA methylation
Investigation of aberrant DNA methylation
aberrant hypermethylation
DNA methyltransferase inhibitors
enzyme catalysing DNA demethylation
aberrant epigenetic landscape
AML-specific alterations
leukemic stem cell self-renewal
leukemic cells
MethylC-seq
epigenetic mark
ATAC-seq
relevant AML mouse models
ChIP-seq
mutated epigenetic regulators
proposed work
increased stem cell self-renewal
distal regulatory regions
high-throughput sequencing methods
high-throughput enhancer screen
TET2 deficiency
tumour suppressive regulatory regions
uncontrollable growth of immature myeloid cells
diverse transcriptional regulators
malignant haematopoiesis Acute myeloid leukaemia
better understanding of mechanisms
leukaemogenesis
promising therapeutic target
aggressive type of blood cancer
binding
targeted improvement of existing therapies
Somatic mutations
positive-selection CRISPR
discovery
advantage
malignancies
link
role
haematopoietic system
genome-wide level
varying degrees of success
clinic
function of transcription factors
reversible nature
loss
sites